| BCBS Federal Medical & Drug | 2.01.87 Confocal Laser Endomicroscopy | 2026-03-01 |
| BCBS Federal Medical & Drug | 2.01.89 Laser Treatment of Onychomycosis | 2026-03-01 |
| BCBS Federal Medical & Drug | 2.01.91 Peroral Endoscopic Myotomy for Treatment of Esophageal Achalasia and Gastroparesis | 2026-03-01 |
| BCBS Federal Medical & Drug | 2.02.31 Myocardial Strain Imaging | 2026-03-01 |
| BCBS Federal Medical & Drug | 2.04.07 Urinary Biomarkers for Cancer Screening, Diagnosis, and Surveillance | 2026-03-01 |
| BCBS Federal Medical & Drug | 2.04.19 Pharmacogenomic and Metabolite Markers for Patients Treated With Thiopurines | 2026-03-01 |
| BCBS Federal Medical & Drug | 2.04.26 Fecal Analysis in the Diagnosis of Intestinal Dysbiosis | 2026-03-01 |
| BCBS Federal Medical & Drug | 2.04.29 Analysis of Human DNA or RNA in Stool Samples as a Technique for Colorectal Cancer Screening | 2026-03-01 |
| BCBS Federal Medical & Drug | 2.04.33 Genetic and Protein Biomarkers for the Diagnosis and Cancer Risk Assessment of Prostate Cancer | 2026-03-01 |
| BCBS Federal Medical & Drug | 2.04.36 Assays of Genetic Expression in Tumor Tissue as a Technique to Determine Prognosis in Patients with Breast Cancer | 2026-03-01 |